BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ozlem Kutlu, Humeyra Nur Kaleli, Ebru Ozer. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular CarcinomaCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8543763
2
Nicolas Lanthier, Peter Stärkel. Treatment of severe alcoholic hepatitis: past, present and futureEuropean Journal of Clinical Investigation 2017; 47(7): 531 doi: 10.1111/eci.12767
3
Zhongbo Liu, Jose Cordoba-Chacon, Rhonda D. Kineman, Bruce N. Cronstein, Radhika Muzumdar, Zhenwei Gong, Haim Werner, Shoshana Yakar. Growth Hormone Control of Hepatic Lipid MetabolismDiabetes 2016; 65(12): 3598 doi: 10.2337/db16-0649
4
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, Olivier Govaere, Mathias Heikenwalder. From NASH to HCC: current concepts and future challengesNature Reviews Gastroenterology & Hepatology 2019; 16(7): 411 doi: 10.1038/s41575-019-0145-7
5
Dinali H. Fernando, Josephine M. Forbes, Peter W. Angus, Chandana B. Herath. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End ProductsInternational Journal of Molecular Sciences 2019; 20(20): 5037 doi: 10.3390/ijms20205037
6
Sébastien Lepreux, Julien Villeneuve, Antoine Dewitte, Annie M. Bérard, Alexis Desmoulière, Jean Ripoche. CD40 signaling and hepatic steatosis: Unanticipated linksClinics and Research in Hepatology and Gastroenterology 2017; 41(4): 357 doi: 10.1016/j.clinre.2016.11.002
7
Mehmet Sayiner, Brian Lam, Pegah Golabi, Zobair M. Younossi. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitisTherapeutic Advances in Gastroenterology 2018; 11: 175628481881150 doi: 10.1177/1756284818811508
8
Lindsey Devisscher, Xavier Verhelst, Isabelle Colle, Hans Van Vlierberghe, Anja Geerts. The role of macrophages in obesity-driven chronic liver diseaseJournal of Leukocyte Biology 2016; 99(5): 693 doi: 10.1189/jlb.5RU0116-016R
9
Kyoko Tomita, Rohit Kohli, Brittany L. MacLaurin, Petra Hirsova, Qianqian Guo, Luz H. Gutierrez Sanchez, Harris A. Gelbard, Burns C. Blaxall, Samar H. Ibrahim. Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitisJCI Insight 2017; 2(15) doi: 10.1172/jci.insight.94488
10
Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, Ariel E. Feldstein. Innate Immunity and Inflammation in NAFLD/NASHDigestive Diseases and Sciences 2016; 61(5): 1294 doi: 10.1007/s10620-016-4049-x
11
Nicolas Lanthier, Nathalie Lin-Marq, Laura Rubbia-Brandt, Sophie Clément, Nicolas Goossens, Laurent Spahr. Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-017-0541-2
12
Samar H Ibrahim, Petra Hirsova, Gregory J Gores. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammationGut 2018; 67(5): 963 doi: 10.1136/gutjnl-2017-315691
13
Juan Du, Xuemei Cao, Junlin Diao, Qijuan Zhang, Chuan Peng, Jibin Li, Xiaoqiu Xiao. Neonatal overfeeding in mice aggravates the development of methionine and choline-deficient diet-induced steatohepatitis in adulthoodGenes & Diseases 2019; 6(1): 68 doi: 10.1016/j.gendis.2017.12.008
14
Kyoko Tomita, Brittany L. Freeman, Steven F. Bronk, Nathan K. LeBrasseur, Thomas A. White, Petra Hirsova, Samar H. Ibrahim. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic SteatohepatitisScientific Reports 2016; 6(1) doi: 10.1038/srep28786
15
Anna Alisi, Guido Carpino, Felipe L. Oliveira, Nadia Panera, Valerio Nobili, Eugenio Gaudio. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical ImplicationsMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/8162421
16
Chi Ma, Qianfei Zhang, Tim F. Greten. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytesThe FEBS Journal 2018; 285(4): 752 doi: 10.1111/febs.14209
17
Zixiong Zhou, Jong Won Kim, Jing Zhao, Jing Qi, Seong Jin Choi, Chae Woong Lim, Moo-Yeol Lee, Kyuhong Lee, Bumseok Kim. Treatment of cigarette smoke extract and condensate differentially potentiates palmitic acid-induced lipotoxicity and steatohepatitis in vitroToxicology in Vitro 2018; 52: 33 doi: 10.1016/j.tiv.2018.05.017
18
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2019; 20(7): 1745 doi: 10.3390/ijms20071745
19
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra. Molecular Pathogenesis of NASHInternational Journal of Molecular Sciences 2016; 17(9): 1575 doi: 10.3390/ijms17091575
20
Komal Sodhi, Krithika Srikanthan, Perrine Goguet-Rubio, Alexandra Nichols, Amrita Mallick, Athar Nawab, Rebecca Martin, Preeya T. Shah, Muhammad Chaudhry, Saroj Sigdel, Mehiar El-Hamdani, Jiang Liu, Zijian Xie, Nader G. Abraham, Joseph I. Shapiro. pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western DietScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00306-5
21
Lisanne L. Blauw, Zhuang Li, Sander S. Rensen, Jan Willem M. Greve, Aswin Verhoeven, Rico J. Derks, Martin Giera, Yanan Wang, Patrick C.N. Rensen. Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETPAtherosclerosis 2018; 275: 149 doi: 10.1016/j.atherosclerosis.2018.06.004